Abemaciclib's up-front approval provides an opportunity to review all 3 currently FDA-approved CDK 4/6 inhibitors. Dosing, drug interaction, and indication differences are discussed.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
